Higher Tumor Rates by Exposure to Electromagnetic Fields
electromagnetic fields stimulate the growth of tumors in mice. This is the result of a new study by researchers from Jacobs University in Bremen, Germany, which was commissioned by the Federal Office for Radiation Protection. The findings do not only confirm a previous pilot study undertaken by the Fraunhofer Institute ITEM in 2010, but expand on the knowledge in two important aspects.
In a study with mice, Alexander Lerchl, Professor of Biology at Jacobs University, and his team could verify that carcinogen-induced tumor rates were significantly higher when the animals were exposed to electromagnetic fields such as those emitted from mobile phones. “The effects on liver and lung tumors, as reported by ITEM in 2010, were fully confirmed,” says Prof. Lerchl who conducted the investigation together with colleagues from Jacobs University and from the University of Wuppertal. “In addition we found a significantly elevated rate of lymphoma due to exposure,” the scientist explains. Furthermore, some of the effects were seen at levels below the exposure limits for the general population.
Alexander Lerchl, however, does not interpret the new data as being a proof for cancer induction through the use of mobile phones. “Our results show that electromagnetic fields obviously enhance the growth of tumors. The assumption that they can cause cancer has not been proven so far,” Prof. Lerchl emphasizes, who has published a large number of studies on the topic. Additional research is necessary to clarify the reasons for the latest results findings. “We can clearly demonstrate the effects. Now new studies must aim at explaining the underlying mechanisms”, Prof. Lerchl concludes.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Targeting a tumor trigger

The Paul Ehrlich and Ludwig Darmstaedter Prize 2022 will be awarded to Katalin Karikó, Özlem Türeci and Uğur Şahin - The three award winners are being honoured for their achievements in the development of mRNA for preventive and therapeutic purposes
Astex Announces Early Transfer of Epigenetics Project to GSK

Ziath acquired by Azenta
CARDIALYSIS And Sticares InterACT Announce Strategic Collaboration
Genzyme Board Unanimously Rejects Sanofi-Aventis Tender Offer
Galapagos receives €4 M milestone for first clinical trial in GlaxoSmithKline alliance
List_of_Hygrophorus_species

Obesity as a risk factor for colorectal cancer underestimated so far - Weight loss before diagnosis obscures correlations
